Standing Order
Legend Biotech Corporation

Dashboard

Legend Biotech Corporation

LEGNNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$3.0B
Price$15.2552w $15.25 – $44.32
Conviction3/ 5
Revenue (TTM)$1.4B
Revenue growth YoY+49.5%
P/E (trailing)—
Gross margin57.0%
Operating margin2.5%
Net margin-0.0%
52w price change-48.0%
Next earnings—

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Nov 20
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Nov 16
    Ownership changeSEC

    SEC Form 4 insider ownership report filed.

  • Nov 10
    Financial resultsSEC

    Legend Biotech 6-K filing with quarterly report for period ended 2026-09-30.

  • Nov 4
    OtherSEC

    Legend Biotech files Form 6-K foreign issuer report.

  • Oct 15
    OtherSEC

    Legend Biotech files Form 6-K with the SEC.

  • Oct 13
    OtherSEC

    Legend Biotech filed Form 6-K on 2026-10-13; no specific items disclosed.

  • Oct 1
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Sep 28
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Sep 28
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 28
    Ownership changeSEC

    Form 4 insider transaction filing

  • Sep 28
    Ownership changeSEC

    Form 4 insider transaction filing

  • Sep 28
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 28
    Ownership changeSEC

    SEC Form 4 insider beneficial ownership report filed.

  • Sep 25
    OtherSEC

    Legend Biotech files Form 6-K foreign issuer report.

  • Sep 24
    OtherSEC

    Foreign issuer Form 6-K filed.

  • Sep 23
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Sep 16
    Ownership changeSEC

    Form 4 insider transaction filing dated 2026-09-16.

  • Sep 15
    OtherSEC

    Legend Biotech files Form 6-K foreign issuer report.

  • Sep 14
    OtherSEC

    Legend Biotech Corporation files Form 6-K with the SEC.

  • Aug 18
    Ownership changeSEC

    Form 4 insider transaction filing

Not financial advice — research and opinion only. Disclosures